DABIGATRAN ETEXILATE 150 MG CP

Dabigatran Etexilate
$0.8705per EA

Strength

150 mg/1

NDC

67877047560

Classification

Generic

Dosage Form

CAPSULE, COATED PELLETS

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208040

On Market Since

6/20/2022

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-1.4%

3M

-3.4%

6M

-20.1%

1Y

-45.0%

3Y

-86.7%

5Y

N/A

All

-87.0%